How much is the Proteasome Inhibitors Market market?

The proteasome inhibitors market market size is estimated to grow at $$ 2.91 bn in 2023. Read More

What is the growth rate of the Proteasome Inhibitors Market market?

The growth rate of the proteasome inhibitors market year-over-year is 7.48%. Read More

Which region held the largest market share in the Proteasome Inhibitors Market market?

North America is the region to held the largest market share with 43% growth. Read More

Who are the key players in the Proteasome Inhibitors Market market?

Amgen Inc., Baxter International Inc., Bio Techne Corp., Bristol Myers Squibb Co., Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, Johnson and Johnson, Kezar Life Sciences .... Read More

Which Segment has the largest market share in the Proteasome Inhibitors Market market?

Route Of Administration is the segment that has the largest market share in the market. Read More

Proteasome Inhibitors Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, UK, Germany, Japan - Size and Forecast 2024-2028

Published: Dec 2023
Pages: 173
SKU: IRTNTR73564

Enjoy complimentary customisation on priority with our Enterprise License!

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Route of Administration
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global proteasome inhibitors market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global proteasome inhibitors market 2018 - 2022 ($ billion)

4.2 Route Of Administration Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Route Of Administration Segment 2018 - 2022 ($ billion)

4.3 Product Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – Product Segment 2018 - 2022 ($ billion)

4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)

4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Route of Administration

6.1 Market segments
- Exhibit 30: Chart on Route of Administration - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Route of Administration - Market share 2023-2028 (%)

6.2 Comparison by Route of Administration
- Exhibit 32: Chart on Comparison by Route of Administration
- Exhibit 33: Data Table on Comparison by Route of Administration

6.3 Oral - Market size and forecast 2023-2028
- Exhibit 34: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
- Exhibit 35: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
- Exhibit 36: Chart on Oral - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Oral - Year-over-year growth 2023-2028 (%)

6.4 Intravenous - Market size and forecast 2023-2028
- Exhibit 38: Chart on Intravenous - Market size and forecast 2023-2028 ($ billion)
- Exhibit 39: Data Table on Intravenous - Market size and forecast 2023-2028 ($ billion)
- Exhibit 40: Chart on Intravenous - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Intravenous - Year-over-year growth 2023-2028 (%)

6.5 Market opportunity by Route of Administration
- Exhibit 42: Market opportunity by Route of Administration ($ billion)
- Exhibit 43: Data Table on Market opportunity by Route of Administration ($ billion)

7 Market Segmentation by Product

7.1 Market segments
- Exhibit 44: Chart on Product - Market share 2023-2028 (%)
- Exhibit 45: Data Table on Product - Market share 2023-2028 (%)

7.2 Comparison by Product
- Exhibit 46: Chart on Comparison by Product
- Exhibit 47: Data Table on Comparison by Product

7.3 VELCADE - Market size and forecast 2023-2028
- Exhibit 48: Chart on VELCADE - Market size and forecast 2023-2028 ($ billion)
- Exhibit 49: Data Table on VELCADE - Market size and forecast 2023-2028 ($ billion)
- Exhibit 50: Chart on VELCADE - Year-over-year growth 2023-2028 (%)
- Exhibit 51: Data Table on VELCADE - Year-over-year growth 2023-2028 (%)

7.4 KYPROLIS - Market size and forecast 2023-2028
- Exhibit 52: Chart on KYPROLIS - Market size and forecast 2023-2028 ($ billion)
- Exhibit 53: Data Table on KYPROLIS - Market size and forecast 2023-2028 ($ billion)
- Exhibit 54: Chart on KYPROLIS - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on KYPROLIS - Year-over-year growth 2023-2028 (%)

7.5 NINLARO - Market size and forecast 2023-2028
- Exhibit 56: Chart on NINLARO - Market size and forecast 2023-2028 ($ billion)
- Exhibit 57: Data Table on NINLARO - Market size and forecast 2023-2028 ($ billion)
- Exhibit 58: Chart on NINLARO - Year-over-year growth 2023-2028 (%)
- Exhibit 59: Data Table on NINLARO - Year-over-year growth 2023-2028 (%)

7.6 Others - Market size and forecast 2023-2028
- Exhibit 60: Chart on Others - Market size and forecast 2023-2028 ($ billion)
- Exhibit 61: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
- Exhibit 62: Chart on Others - Year-over-year growth 2023-2028 (%)
- Exhibit 63: Data Table on Others - Year-over-year growth 2023-2028 (%)

7.7 Market opportunity by Product
- Exhibit 64: Market opportunity by Product ($ billion)
- Exhibit 65: Data Table on Market opportunity by Product ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 67: Chart on Market share by geography 2023-2028 (%)
- Exhibit 68: Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Exhibit 69: Chart on Geographic comparison
- Exhibit 70: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2023-2028
- Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 Japan - Market size and forecast 2023-2028
- Exhibit 91: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
- Exhibit 92: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
- Exhibit 93: Chart on Japan - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on Japan - Year-over-year growth 2023-2028 (%)

9.9 UK - Market size and forecast 2023-2028
- Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)

9.10 Canada - Market size and forecast 2023-2028
- Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
- Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
- Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)

9.11 Germany - Market size and forecast 2023-2028
- Exhibit 103: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 104: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 105: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 106: Data Table on Germany - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Exhibit 107: Market opportunity by geography ($ billion)
- Exhibit 108: Data Tables on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 109: Impact of drivers and challenges in 2023 and 2028

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 110: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 111: Overview on factors of disruption

11.4 Industry risks
- Exhibit 112: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 113: Vendors covered

12.2 Market positioning of vendors
- Exhibit 114: Matrix on vendor position and classification

12.3 Amgen Inc.
- Exhibit 115: Amgen Inc. - Overview
- Exhibit 116: Amgen Inc. - Product / Service
- Exhibit 117: Amgen Inc. - Key offerings

12.4 Baxter International Inc.
- Exhibit 118: Baxter International Inc. - Overview
- Exhibit 119: Baxter International Inc. - Business segments
- Exhibit 120: Baxter International Inc. - Key news
- Exhibit 121: Baxter International Inc. - Key offerings
- Exhibit 122: Baxter International Inc. - Segment focus

12.5 Bio Techne Corp.
- Exhibit 123: Bio Techne Corp. - Overview
- Exhibit 124: Bio Techne Corp. - Business segments
- Exhibit 125: Bio Techne Corp. - Key offerings
- Exhibit 126: Bio Techne Corp. - Segment focus

12.6 Bristol Myers Squibb Co.
- Exhibit 127: Bristol Myers Squibb Co. - Overview
- Exhibit 128: Bristol Myers Squibb Co. - Product / Service
- Exhibit 129: Bristol Myers Squibb Co. - Key news
- Exhibit 130: Bristol Myers Squibb Co. - Key offerings

12.7 Fresenius SE and Co. KGaA
- Exhibit 131: Fresenius SE and Co. KGaA - Overview
- Exhibit 132: Fresenius SE and Co. KGaA - Business segments
- Exhibit 133: Fresenius SE and Co. KGaA - Key news
- Exhibit 134: Fresenius SE and Co. KGaA - Key offerings
- Exhibit 135: Fresenius SE and Co. KGaA - Segment focus

12.8 Johnson and Johnson
- Exhibit 136: Johnson and Johnson - Overview
- Exhibit 137: Johnson and Johnson - Business segments
- Exhibit 138: Johnson and Johnson - Key news
- Exhibit 139: Johnson and Johnson - Key offerings
- Exhibit 140: Johnson and Johnson - Segment focus

12.9 Kezar Life Sciences Inc.
- Exhibit 141: Kezar Life Sciences Inc. - Overview
- Exhibit 142: Kezar Life Sciences Inc. - Product / Service
- Exhibit 143: Kezar Life Sciences Inc. - Key news
- Exhibit 144: Kezar Life Sciences Inc. - Key offerings

12.10 LifeSensors Inc.
- Exhibit 145: LifeSensors Inc. - Overview
- Exhibit 146: LifeSensors Inc. - Product / Service
- Exhibit 147: LifeSensors Inc. - Key offerings

12.11 Merck and Co. Inc.
- Exhibit 148: Merck and Co. Inc. - Overview
- Exhibit 149: Merck and Co. Inc. - Business segments
- Exhibit 150: Merck and Co. Inc. - Key news
- Exhibit 151: Merck and Co. Inc. - Key offerings
- Exhibit 152: Merck and Co. Inc. - Segment focus

12.12 Novartis AG
- Exhibit 153: Novartis AG - Overview
- Exhibit 154: Novartis AG - Business segments
- Exhibit 155: Novartis AG - Key offerings
- Exhibit 156: Novartis AG - Segment focus

12.13 Pfizer Inc.
- Exhibit 157: Pfizer Inc. - Overview
- Exhibit 158: Pfizer Inc. - Product / Service
- Exhibit 159: Pfizer Inc. - Key news
- Exhibit 160: Pfizer Inc. - Key offerings

12.14 QLi5 Therapeutics
- Exhibit 161: QLi5 Therapeutics - Overview
- Exhibit 162: QLi5 Therapeutics - Product / Service
- Exhibit 163: QLi5 Therapeutics - Key offerings

12.15 Takeda Pharmaceutical Co. Ltd.
- Exhibit 164: Takeda Pharmaceutical Co. Ltd. - Overview
- Exhibit 165: Takeda Pharmaceutical Co. Ltd. - Product / Service
- Exhibit 166: Takeda Pharmaceutical Co. Ltd. - Key news
- Exhibit 167: Takeda Pharmaceutical Co. Ltd. - Key offerings

12.16 TG Therapeutics Inc.
- Exhibit 168: TG Therapeutics Inc. - Overview
- Exhibit 169: TG Therapeutics Inc. - Product / Service
- Exhibit 170: TG Therapeutics Inc. - Key offerings

12.17 Thermo Fisher Scientific Inc.
- Exhibit 171: Thermo Fisher Scientific Inc. - Overview
- Exhibit 172: Thermo Fisher Scientific Inc. - Business segments
- Exhibit 173: Thermo Fisher Scientific Inc. - Key news
- Exhibit 174: Thermo Fisher Scientific Inc. - Key offerings
- Exhibit 175: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 176: Inclusions checklist
- Exhibit 177: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 178: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 179: Research methodology
- Exhibit 180: Validation techniques employed for market sizing
- Exhibit 181: Information sources

13.5 List of abbreviations
- Exhibit 182: List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES